Technology

Ambry Genetics announces the launch of cardiovascular genetic testing panels for inherited cardiomyopathies and arrhythmias. These feature an intuitive, tiered approach to testing for hypertrophic cardiomyopathy, long QT syndrome and Brugada syndrome.

Home January 13, 2015
Home
Technology

Daiichi Sankyo Co. Ltd. announced that the U.S. Food and Drug Administration (FDA) has approved Savaysa (edoxaban) tablets, an oral, once-daily selective factor Xa-inhibitor, to reduce the risk of stroke and systemic embolism (SE) in patients with non-valvular atrial fibrillation (NVAF).

Home January 13, 2015
Home
News

Lithoplasty is a balloon-based technology that utilizes integrated lithotripsy to disrupt both superficial and deep calcium and normalize vessel wall compliance prior to low-pressure balloon dilatation.

Home January 13, 2015
Home
News

ECRI Institute’s 2015 Top 10 Hospital C-Suite Watch List, available as a free public service, answers key questions on new and emerging health technologies that potentially provide new ways to treat patients, improve care and reduce costs.

Home January 13, 2015
Home
News

CardioFocus Inc., developer of the HeartLight Endoscopic Ablation System for the treatment of atrial fibrillation (AF), announced that it has executed an exclusive, multi-year distribution agreement with Japan Lifeline Co. Ltd.

Home January 12, 2015
Home
News

Transcatheter Technologies GmbH has announced that it is expanding its product family to include Tresillo, a transcatheter mitral valve implantation (TMVI) version.

Home January 12, 2015
Home
News

Medtronic, Inc. announced the initiation of a randomized clinical trial in Europe to assess the benefits of ablation using the Medtronic Artic Front Advance cryoballoon as a first-line treatment for atrial fibrillation (AF) patients.

Home January 12, 2015
Home
News

W. L. Gore & Associates Inc. announced that the Gore Viabahn Endoprosthesis has received CE Mark approval to improve blood flow in symptomatic obstruction of peripheral veins, excluding the venae cavae and pulmonary veins.

Home January 09, 2015
Home
News

CardioKinetix Inc. announced results of a pooled analysis study of the catheter-based Parachute ventricular partitioning device. Twelve-month clinical data from PARACHUTE III, a study of 100 post-market European patients with ischemic heart failure treated consecutively between 2011 and 2013, were presented at the 2014 TCT Conference in Washington, D.C., and the 2014 HFSA Conference in Las Vegas.

Home January 09, 2015
Home
News

The Healthcare Colloquium announced that CHI Franciscan Health is the first Accredited Heart Failure System in the Northwest.

Home January 09, 2015
Home
Case Study

With today’s aging population in the United States, we are experiencing an increased occurrence of cardiovascular disease including heart failure, degenerative valve disease and atrial fibrillation. These clinical challenges, along with changes in healthcare economics and standards, require efficient, effective and streamlined diagnostic solutions. These solutions must deliver critical added benefits including:

Home January 09, 2015
Home
News

Covidien announced it has received CE Mark approval for its Stellarex drug-coated angioplasty balloon (DCB).

Home January 09, 2015
Home
News

At the IEEE medical Imaging Conference (MIC) in November, ContextVision co-presented with Texas Instruments and High Performance Consulting on new research on 3-D adaptive filtering.

Home January 08, 2015
Home
News

Medtronic's roughly $43 billion acquisition and merger with Covidien has been widely discussed in the media for its U.S. Federal tax implications, but it's also creating a stronger leading player in one of the fastest growing device markets, according to Kalorama Information.

Home January 08, 2015
Home
News

Stentys announced that the Self-Apposing Stent has been implanted more than 10,000 times in patients worldwide

Home January 08, 2015
Home
Subscribe Now